These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26475522)

  • 1. Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators.
    Malosh C; Turlington M; Bridges TM; Rook JM; Noetzel MJ; Vinson PN; Steckler T; Lavreysen H; Mackie C; Bartolomé-Nebreda JM; Conde-Ceide S; Martínez-Viturro CM; Piedrafita M; Sánchez-Casado MR; Macdonald GJ; Daniels JS; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Nov; 25(22):5115-20. PubMed ID: 26475522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery and SAR of a novel series of metabotropic glutamate receptor 5 positive allosteric modulators with high ligand efficiency.
    Turlington M; Noetzel MJ; Bridges TM; Vinson PN; Steckler T; Lavreysen H; Mackie C; Bartolomé-Nebreda JM; Conde-Ceide S; Tong HM; Macdonald GJ; Daniels JS; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3641-6. PubMed ID: 24961642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and SAR of novel series of imidazopyrimidinones and dihydroimidazopyrimidinones as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu5).
    Martín-Martín ML; Bartolomé-Nebreda JM; Conde-Ceide S; Alonso de Diego SA; López S; Martínez-Viturro CM; Tong HM; Lavreysen H; Macdonald GJ; Steckler T; Mackie C; Bridges TM; Daniels JS; Niswender CM; Noetzel MJ; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1310-7. PubMed ID: 25683622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias.
    Arsova A; Møller TC; Hellyer SD; Vedel L; Foster SR; Hansen JL; Bräuner-Osborne H; Gregory KJ
    Mol Pharmacol; 2021 May; 99(5):328-341. PubMed ID: 33602724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary investigation of 6,7-dihydropyrazolo[1,5-a]pyrazin-4-one derivatives as a novel series of mGlu5 receptor positive allosteric modulators with efficacy in preclinical models of schizophrenia.
    Conde-Ceide S; Alcázar J; Alonso de Diego SA; López S; Martín-Martín ML; Martínez-Viturro CM; Pena MA; Tong HM; Lavreysen H; Mackie C; Bridges TM; Daniels JS; Niswender CM; Jones CK; Macdonald GJ; Steckler T; Conn PJ; Stauffer SR; Lindsley CW; Bartolomé-Nebreda JM
    Bioorg Med Chem Lett; 2016 Jan; 26(2):429-434. PubMed ID: 26684851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel series of metabotropic glutamate receptor 5 negative allosteric modulators based on a 4,5,6,7-tetrahydropyrazolo[1,5-a]pyridine core.
    Duvey G; Perry B; Le Poul E; Poli S; Bonnet B; Lambeng N; Charvin D; Donovan-Rodrigues T; Haddouk H; Gagliardi S; Rocher JP
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4523-7. PubMed ID: 23850200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Alkylpyrido[1',2':1,5]pyrazolo-[4,3-d]pyrimidin-4-amines: A new series of negative allosteric modulators of mGlu1/5 with CNS exposure in rodents.
    Felts AS; Rodriguez AL; Morrison RD; Venable DF; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2016 Apr; 26(8):1894-900. PubMed ID: 26988308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement.
    Gregory KJ; Herman EJ; Ramsey AJ; Hammond AS; Byun NE; Stauffer SR; Manka JT; Jadhav S; Bridges TM; Weaver CD; Niswender CM; Steckler T; Drinkenburg WH; Ahnaou A; Lavreysen H; Macdonald GJ; Bartolomé JM; Mackie C; Hrupka BJ; Caron MG; Daigle TL; Lindsley CW; Conn PJ; Jones CK
    J Pharmacol Exp Ther; 2013 Nov; 347(2):438-57. PubMed ID: 23965381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploration of allosteric agonism structure-activity relationships within an acetylene series of metabotropic glutamate receptor 5 (mGlu5) positive allosteric modulators (PAMs): discovery of 5-((3-fluorophenyl)ethynyl)-N-(3-methyloxetan-3-yl)picolinamide (ML254).
    Turlington M; Noetzel MJ; Chun A; Zhou Y; Gogliotti RD; Nguyen ED; Gregory KJ; Vinson PN; Rook JM; Gogi KK; Xiang Z; Bridges TM; Daniels JS; Jones C; Niswender CM; Meiler J; Conn PJ; Lindsley CW; Stauffer SR
    J Med Chem; 2013 Oct; 56(20):7976-96. PubMed ID: 24050755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanism.
    Bridges TM; Rook JM; Noetzel MJ; Morrison RD; Zhou Y; Gogliotti RD; Vinson PN; Xiang Z; Jones CK; Niswender CM; Lindsley CW; Stauffer SR; Conn PJ; Daniels JS
    Drug Metab Dispos; 2013 Sep; 41(9):1703-14. PubMed ID: 23821185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further optimization of the mGlu5 PAM clinical candidate VU0409551/JNJ-46778212: Progress and challenges towards a back-up compound.
    Zhou Y; Malosh C; Conde-Ceide S; Martínez-Viturro CM; Alcázar J; Lavreysen H; Mackie C; Bridges TM; Daniels JS; Niswender CM; Jones CK; Macdonald GJ; Steckler T; Conn PJ; Stauffer SR; Bartolomé-Nebreda JM; Lindsley CW
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3515-9. PubMed ID: 26183084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and optimisation of a series of tetrahydrobenzotriazoles as metabotropic glutamate receptor 5-selective positive allosteric modulators that improve performance in a preclinical model of cognition.
    Ellard JM; Madin A; Philps O; Hopkin M; Henderson S; Birch L; O'Connor D; Arai T; Takase K; Morgan L; Reynolds D; Talma S; Howley E; Powney B; Payne AH; Hall A; Gartlon JE; Dawson LA; Castro L; Atkinson PJ
    Bioorg Med Chem Lett; 2015 Dec; 25(24):5792-6. PubMed ID: 26531152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabotropic glutamate receptor 5 (mGlu
    Hellyer SD; Albold S; Sengmany K; Singh J; Leach K; Gregory KJ
    J Neurochem; 2019 Nov; 151(3):301-315. PubMed ID: 31376155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).
    Christopher JA; Aves SJ; Bennett KA; Doré AS; Errey JC; Jazayeri A; Marshall FH; Okrasa K; Serrano-Vega MJ; Tehan BG; Wiggin GR; Congreve M
    J Med Chem; 2015 Aug; 58(16):6653-64. PubMed ID: 26225459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydronaphthyridine and dihydronaphthyridinone ethers as positive allosteric modulators of the metabotropic glutamate receptor 5 (mGlu₅).
    Turlington M; Malosh C; Jacobs J; Manka JT; Noetzel MJ; Vinson PN; Jadhav S; Herman EJ; Lavreysen H; Mackie C; Bartolomé-Nebreda JM; Conde-Ceide S; Martín-Martín ML; Tong HM; López S; MacDonald GJ; Steckler T; Daniels JS; Weaver CD; Niswender CM; Jones CK; Conn PJ; Lindsley CW; Stauffer SR
    J Med Chem; 2014 Jul; 57(13):5620-37. PubMed ID: 24914612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of 6-(pyrimidin-5-ylmethyl)quinoline-8-carboxamide negative allosteric modulators of metabotropic glutamate receptor subtype 5.
    Felts AS; Rodriguez AL; Morrison RD; Blobaum AL; Byers FW; Daniels JS; Niswender CM; Conn PJ; Lindsley CW; Emmitte KA
    Bioorg Med Chem Lett; 2018 Jun; 28(10):1679-1685. PubMed ID: 29705142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism based neurotoxicity of mGlu5 positive allosteric modulators--development challenges for a promising novel antipsychotic target.
    Parmentier-Batteur S; Hutson PH; Menzel K; Uslaner JM; Mattson BA; O'Brien JA; Magliaro BC; Forest T; Stump CA; Tynebor RM; Anthony NJ; Tucker TJ; Zhang XF; Gomez R; Huszar SL; Lambeng N; Fauré H; Le Poul E; Poli S; Rosahl TW; Rocher JP; Hargreaves R; Williams TM
    Neuropharmacology; 2014 Jul; 82():161-73. PubMed ID: 23291536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro binding of a radio-labeled positive allosteric modulator for metabotropic glutamate receptor subtype 5.
    Zysk JR; Spear N; Fieles W; Stein MM; Sygowski LS; King MM; Hoesch V; Hastings R; Brockel B; Do M; Ström P; Gadient R; Chhajlani V; Elmore CS; Maier DL
    Synapse; 2013 Mar; 67(3):135-44. PubMed ID: 23150216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of ((S)-5-(methoxymethyl)-7-(1-methyl-1H-indol-2-yl)-2-(trifluoromethyl)-4,7-dihydropyrazolo[1,5-a]pyrimidin-6-yl)((S)-2-(3-methylisoxazol-5-yl)pyrrolidin-1-yl)methanone as a potent and selective I(Kur) inhibitor.
    Finlay HJ; Lloyd J; Vaccaro W; Kover A; Yan L; Bhave G; Prol J; Huynh T; Bhandaru R; Caringal Y; DiMarco J; Gan J; Harper T; Huang C; Conder ML; Sun H; Levesque P; Blanar M; Atwal K; Wexler R
    J Med Chem; 2012 Apr; 55(7):3036-48. PubMed ID: 22409629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure-activity relationships and biological evaluation of 4,5,6,7-tetrahydropyrazolopyrazines as metabotropic glutamate receptor 5 negative allosteric modulators.
    Hirose W; Kato Y; Yamamoto T; Kassai M; Takata M; Hayashi S; Arai Y; Imai S; Yoshida K
    Bioorg Med Chem Lett; 2016 Aug; 26(16):3866-9. PubMed ID: 27432763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.